Welcome to the e-CCO Library!

P0696: ADSS: A novel AI-derived metric for quantifying disease severity and extent in ulcerative colitis
Year: 2025
Source: ECCO'25
Authors: Beckerx7x7x7 B.(1);Fraesslex7x7x7 S.(1);Yaox7x7x7 H.(2);Luscherx7x7x7 J.(2);Giryckix7x7x7 R.(3);Machurax7x7x7 B.(4);Czornikx7x7x7 J.(4);Goslinskyx7x7x7 J.(4);Piturax7x7x7 M.(4);Levittex7x7x7 S.(5)*;Karrerx7x7x7 T.(6);Abbasix7x7x7 S.(6);Arus Pousx7x7x7 J.(1);Fisherx7x7x7 E.(7);Bojicx7x7x7 D.(7);Richmondx7x7x7 D.(2);Bigorgnex7x7x7 A.(7);Prunottox7x7x7 M.(8);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0697: Ozanimod Inhibits Pro-Inflammatory Mediators of the IL-17 Pathway in the Tissues of Participants in the Phase 2 TOUCHSTONE Study
Year: 2025
Source: ECCO'25
Authors: Zhangx7x7x7 J.(1);Chenx7x7x7 X.(2);Wux7x7x7 C.(2);Petersenx7x7x7 A.K.(3);Mehandrux7x7x7 S.(4);D’Haensx7x7x7 G.(5);Harrisx7x7x7 S.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0698: Early faecal calprotectin predicts clinical outcomes in Acute Severe Ulcerative Colitis: results from PREDICT-UC
Year: 2025
Source: ECCO'25
Authors: Li Wai Suenx7x7x7 C.(1x7x7x72)*;Choyx7x7x7 M.C.(1x7x7x72);Conx7x7x7 D.(1x7x7x72);Driverx7x7x7 K.(3);Bruenx7x7x7 D.(3);Glasonx7x7x7 J.(3);Bonellix7x7x7 F.(4);Boydx7x7x7 K.(1);Penax7x7x7 R.(1);Burrellx7x7x7 K.(1);Rosellax7x7x7 O.(1);Proudx7x7x7 D.(5);Brouwerx7x7x7 R.(5);Gorelikx7x7x7 A.(6);Liewx7x7x7 D.(7);Connellx7x7x7 W.(8);Wrightx7x7x7 E.(8);Taylorx7x7x7 K.(9);Pudipeddix7x7x7 A.(10);Sawersx7x7x7 M.(11);Christensenx7x7x7 B.(12);Ngx7x7x7 W.(13);Begunx7x7x7 J.(14);Radford-Smithx7x7x7 G.(15);Gargx7x7x7 M.(16);Martinx7x7x7 N.(17);van Langenbergx7x7x7 D.(18);Dingx7x7x7 N.(8);Beswickx7x7x7 L.(11);Leongx7x7x7 R.(10);Sparrowx7x7x7 M.(9);De Cruzx7x7x7 P.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0699: Comparative Effectiveness and Safety of Denosumab Versus Bisphosphonates in Osteoporosis Management Among Patients with Inflammatory Bowel Disease: A U.S. Propensity Matched Cohort Study
Year: 2025
Source: ECCO'25
Authors: Khataniarx7x7x7 H.(1);Desaix7x7x7 A.(2);Kochharx7x7x7 G.(3)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P069: Artificial intelligence (AI)-filtered Videos for Accelerated Scoring of Colonoscopy Videos in Ulcerative Colitis Clinical Trials
Year: 2021
Source: ECCO'21 Virtual
Authors: Gutierrez Becker, B.(1);Giuffrida, E.(2);Mangia, M.(2);Arcadu, F.(1);Whitehill, V.(3);Guaraglia, D.(4);Schwartz, M.(4);Sabouni, R.(4);Prunotto, M.(5);Oh, Y.(6);Daperno, M.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P069: Design and delivery of anti-oxidant inorganic complexes mimicking the superoxide dismutase for inflammatory bowel diseases treatment.
Year: 2022
Source: ECCO'22
Authors: Schanne, G.(1);Zoumpoulaki, M.(2);Demignot, S.(3);Delsuc, N.(2);Policar, C.(2);Seksik, P.(3);
Created: Friday, 11 February 2022, 3:52 PM
P069: Elevated adaptive immune responses to multiple Lachnospiraceae bacterial flagellins in therapy-naïve pediatric CD patients are associated with distinct immune pathology.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Barendregt, D.(1)*;Joosse, M.E.(1);Alexander, K.L.(2);Costes, L.M.M.(1);Tindemans, I.(1);Simons-Oosterhuis, Y.(1);Aardoom, M.A.(3);Klomberg, R.C.W.(3);Heredia, M.(1);Hulleman- van Haaften, D.H.(1);Tuk, B.(1);Nugteren, S.(1);Doukas, M.(4);Escher, J.C.(3);de Ridder, L.(3);Elson, C.O.(2);Samsom, J.N.(1);
Created: Friday, 14 July 2023, 10:48 AM
P069: Intraperitoneal injection of bone marrow derived-mesenchymal stem cells increases total number of colon-infiltrating inflammatory dendritic cells and macrophages and aggravates colitis in BALBc mice
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Acovic1*, B. Simovic Markovic2, M. Gazdic2, A. Arsenijevic2, A. Volarevic3, T. Kanjevac1, N. Jovicic2, J. Jakovljevic2, M. Arsenijevic2, N. Arsenijevic2, M.L. Lukic2, V. Volarevic2

Created: Thursday, 21 February 2019, 9:14 AM
P069: New methylation biomarker panel of inflammatory Mucosa in Korean Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. M. Lee1, T. O. Kim*2

Created: Friday, 22 February 2019, 9:41 AM
P069: Sympathetic but not vagal intestinal innervation regulates murine dextran sodium sulphate-induced colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Willemze R.*1, Welting O.1, van Hamersveld P.1, Sridhar A.2, Vervoordeldonk M.2, Seppen J.1, de Jonge W.1

Created: Wednesday, 20 February 2019, 10:36 AM
P069: TD-1473, a novel, potent, and orally administered, GI-targeted, pan-Janus kinase (JAK) inhibitor
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Beattie*, P. Tsuruda, F. Shen, P. Brassil, C. Langrish, J. Janc, Z. Ren, R. Hudson, J. Smith, S. Hegde

Created: Friday, 22 February 2019, 9:49 AM
P070 Machine learning approaches to identify IBD biomarkers from longitudinal microbiome data
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Madgwick1,2, P. Sudhakar1,2,3, N.S. Tabib3, P. Norvaisas4, P. Creed4, B. Verstockt3,5, S. Vermeire3,5, T. Korcsmáros1,2

Created: Thursday, 30 January 2020, 10:12 AM
P0700: Impact of filgotinib on health-related quality of life over 3 years in Japanese patients with Ulcerative Colitis: A post hoc analysis of the SELECTION and SELECTION long-term extension trials
Year: 2025
Source: ECCO'25
Authors: Matsuokax7x7x7 K.(1)*;Schreiberx7x7x7 S.(2);Hatax7x7x7 E.(3);Kaisex7x7x7 T.(3);Hibix7x7x7 T.(4);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0701: Trans-continental analysis of determinants of response to COVID-19 vaccination in 2268 patients with Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Wongx7x7x7 S.Y.(1)*;Moranx7x7x7 H.R.(1);Rajauriax7x7x7 P.(1);Giselbrechtx7x7x7 E.(1);Wellensx7x7x7 J.(2);Vermierex7x7x7 S.(2);Watanabex7x7x7 K.(3);Kamikozurux7x7x7 K.(4);Halfvarsonx7x7x7 J.(5);Bergemalmx7x7x7 D.(5);Silverbergx7x7x7 M.S.(6);Ngx7x7x7 S.C.(7);Makx7x7x7 J.W.Y.(8);Ahujax7x7x7 V.(9);Virmanix7x7x7 S.(9);Kediax7x7x7 S.(9);Lindsayx7x7x7 J.O.(10);Abreux7x7x7 M.T.(11);Allezx7x7x7 M.(12);Rubinx7x7x7 D.T.(13);Duttax7x7x7 U.(14);Sinhax7x7x7 S.K.(14);Sharmax7x7x7 V.(14);Samantax7x7x7 J.(14);Shahx7x7x7 J.(14);Singhx7x7x7 A.K.(14);Kaurx7x7x7 H.(14);Kaplanx7x7x7 G.(15);Thompsonx7x7x7 C.(16);Colombelx7x7x7 J.F.(1);Satsangix7x7x7 J.(17);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0702: Efficacy of subcutaneous infliximab maintenance therapy according to disease location in patients with moderate-to-severe Crohn’s disease: A post hoc analysis of the Phase 3 LIBERTY-CD study
Year: 2025
Source: ECCO'25
Authors: Schreiberx7x7x7 S.W.(1)*;Colombelx7x7x7 J.F.(2);Dubinskyx7x7x7 M.C.(3);Sandsx7x7x7 B.E.(2);Abrahamx7x7x7 B.P.(4);Regueirox7x7x7 M.(5);Danesex7x7x7 S.(6);Parkx7x7x7 H.(7);Kimx7x7x7 D.H.(7);Leex7x7x7 Y.N.(7);Hanauerx7x7x7 S.B.(8);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0703: Risk factors and nomogram for massive postoperative gastrointestinal bleeding in patients with Crohn's disease: a multicenter retrospective study
Year: 2025
Source: ECCO'25
Authors: Zhangx7x7x7 M.(1);Dingx7x7x7 Z.(1);Wangx7x7x7 Y.(1);Lix7x7x7 Y.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0704: A Multicenter Study Evaluating the Persistencex7x7x7 Effectivenessx7x7x7 and Safety of Methotrexate in Patients with Inflammatory Bowel Disease: The MICI-METHO Study
Year: 2025
Source: ECCO'25
Authors: Caronx7x7x7 B.(1)*;Kirchgesnerx7x7x7 J.(2);Nachuryx7x7x7 M.(3);Bouguenx7x7x7 G.(4);Uzzanx7x7x7 M.(5);Buissonx7x7x7 A.(6);Le Cosquerx7x7x7 G.(7);Vuittonx7x7x7 L.(8);Seksikx7x7x7 P.(2);Petitx7x7x7 S.(9);Wilsx7x7x7 P.(3);Nanceyx7x7x7 S.(10);Altweggx7x7x7 R.(11);Hupex7x7x7 M.(12);Fumeryx7x7x7 M.(13);Roblinx7x7x7 X.(14);Lahariex7x7x7 D.(15);Hebuternex7x7x7 X.(16);Baumannx7x7x7 C.(17);Vicautx7x7x7 E.(18);Peyrin-Birouletx7x7x7 L.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0705: Features of optimal disease control in Crohn’s disease and Ulcerative Colitis: Views on IBD Expectations and Well-being by Patients and Treatment providers
Year: 2025
Source: ECCO'25
Authors: Rubin x7x7x7 D.T.(1);Potts Bleakman x7x7x7 A.(2)*;Orleck x7x7x7 K.(3);Hibi x7x7x7 T.(4);Bernstein x7x7x7 M.(5);Kearns x7x7x7 K.(6);Patel x7x7x7 A.(7);Folian x7x7x7 S.(8);Kayhan x7x7x7 C.(2);Baygani x7x7x7 S.(9);Flynn x7x7x7 E.(10);Favia x7x7x7 A.(11);Knight x7x7x7 H.(12);Castellano x7x7x7 G.(13);Schreiber x7x7x7 S.(14);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0706: Dose intensification of subcutaneous vedolizumab is an effective and safe option in Inflammatory Bowel Disease patients: Results from the multicentre OPTI-VEDO study
Year: 2025
Source: ECCO'25
Authors: Wilsx7x7x7 P.(1)*;Altweggx7x7x7 R.(2);Buissonx7x7x7 A.(3);Vuittonx7x7x7 L.(4);Nanceyx7x7x7 S.(5);Richardx7x7x7 N.(6);Fumeryx7x7x7 M.(7);Bouguenx7x7x7 G.(8);Guillox7x7x7 L.(9);Caronx7x7x7 B.(10);Duveaux7x7x7 N.(11);Stefanescux7x7x7 C.(12);Pelletierx7x7x7 A.L.(13);Reenaersx7x7x7 C.(14);Gillettax7x7x7 C.(15);Uzzanx7x7x7 M.(16);Arabx7x7x7 N.(17);Lahariex7x7x7 D.(18);Vidonx7x7x7 M.(19);Amiotx7x7x7 A.(20);Le berrex7x7x7 C.(21);Kirchgesnerx7x7x7 J.(22);Dewitx7x7x7 O.(23);Simonx7x7x7 M.(24);Goutorbex7x7x7 F.(25);Vicautx7x7x7 E.(26);Peyrin-Birouletx7x7x7 L.(10);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0707: Impact of age of disease diagnosis on disease phenotype and severity in patients with Inflammatory Bowel Diseases
Year: 2025
Source: ECCO'25
Authors: Panayiotoux7x7x7 S.(1)*;Orfanoudakix7x7x7 E.(1x7x7x72);Papatzeloux7x7x7 I.(1);Foteinogiannopouloux7x7x7 K.(1);Theodorakix7x7x7 E.(1);Drygiannakisx7x7x7 I.(1);E. Koutroubakisx7x7x7 I.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session